Metofoli N Syrup contains Metronidazole 200 mg and Norfloxacin 100 mg per 5 ml, a dual-action antimicrobial syrup designed for effective management of bacterial and protozoal gastrointestinal infections. Metronidazole targets anaerobic bacteria and protozoa, while Norfloxacin provides broad-spectrum antibacterial coverage, ensuring comprehensive infection control.
Clinically, this syrup is indicated for acute diarrhea, dysentery, gastroenteritis, and mixed bacterial or protozoal gut infections. Its dual mechanism reduces pathogen load, alleviates symptoms such as abdominal pain, cramping, and diarrhea, and helps prevent complications associated with severe gastrointestinal infections.
The syrup formulation ensures accurate dosing, rapid absorption, and patient-friendly administration, particularly suitable for children, elderly patients, and those with difficulty swallowing tablets. It is ideal for hospitals, pediatric clinics, nursing homes, and retail pharmacies requiring high-quality gastrointestinal anti-infective therapy.
Metofoli N Syrup also supports faster recovery, maintenance of gut flora balance, and prevention of infection recurrence. Its combination of Metronidazole and Norfloxacin offers a safe, effective, and evidence-based solution for managing bacterial and protozoal gastrointestinal infections in routine clinical practice.